Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 7, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Cure of Antibiotic Resistance to be expected from Venom of Wasps

Cognizant Data Analyst Life Science Recruitment | Apply Online

Is zinc deficiency leading to more COVID deaths?

Cure of Antibiotic Resistance to be expected from Venom of Wasps
  • BiotechToday
  • World

Cure of Antibiotic Resistance to be expected from Venom of Wasps

bioxone October 17, 2020October 17, 2020

Devyani Goswami, Amity University Kolkata

Scientists have been worried due to the growth of antibiotic resistance among the population for decades. As new antibiotics come into the market the rate of developing antibiotic resistance infection goes on increasing. For about more than 500,000 people die worldwide each year due to antibiotic resistance infection. The researchers have come up with the assurity that the venom of the Asian wasp, Vespula lewisii could be used to cure the antibiotic resistance.

The researchers extracted the venom from the wasps and altered a highly toxic small protein molecule, mastoparan-L into a synthetic antimicrobial entity. They altered an N- terminus motif conserved among natural peptides with potent immunomodulatory and antimicrobial activities. “The resulting peptide, mast-MO showed increased antibacterial properties compared to standard-of-care antibiotics both in-vitro and in-vivo, and potentiated the activity of different classes of antibiotics”, according to the authors. 

They have conducted their tests on mice infected with incurable and lethal E.coli. Eighty percent of the treated animals survived, while those that received the natural mastoparan-L peptide were on the verge of death. In comparison to mastoparan-L, mast-MO was successfully and safely administered in higher doses.

Will this be a successful discovery that remains behind many trials?

Also read: Ex-situ DNA synthesis accelerated

REFERENCE: 1) Wasp venom used to potentially combat antibiotic-resistance bacteria

https://www.genengnews.com/news/wasp-venom-used-to-pottentially-combat-antibiotic-resistant-bacteria/

2) Repurposing a peptide toxin from wasp venom into anti-infectives with dual antimicrobial and immunomodulatory properties – Osmar N. Silva et al. 

https://www.pnas.org/content/early/2020/10/07/2012379117

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged antibiotic resistance e.coli mast-MO mastoparan-L Vespula lewisii

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Is zinc deficiency leading to more COVID deaths?

bioxone October 17, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA Recently, researchers from various universities in Spain hypothesized that serum zinc level had a particular influence on COVID-19 patients, further stating it as a useful biomarker in predicting COVID-19 in its’ early stage. In an observational study of 249 COVID-19 patients to identify the severity of the disease and to […]

zinc deficiency

Related Post

  • BiotechToday
  • World

Treating Irritable Bowel Syndrome with Low FODMAPs Diet

BioTech Today July 26, 2021July 26, 2021

Subhajit Nan, Amity University, Kolkata. Scientists have recently conducted clinical trials and made a critical meta-analysis on the effect of FODMAPS diet (abbreviated as fermentable oligosaccharides, disaccharides, monosaccharides, and polyols). These are considered to influence the stool habits and the overall quality of life of the patients suffering from irritable bowel syndrome (IBS). Subgroup analyses […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Hypertension cause hyper-inflammation and delays viral clearance for COVID-19 patients

bioxone December 30, 2020December 30, 2020

Devyani Goswami, Amity University Kolkata Hypertension and cardiovascular diseases are considered as vital risk factors for critical disease progression for COVID-19 contracted patients. 1 out of every 5 individual suffers from hypertension. Hypertension is observed to develop serious problems in the later stage of the infection, as these patients are more likely to develop pneumonia […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • India

Tata to launch Moderna COVID-19 vaccine in India

bioxone January 28, 2021January 28, 2021

Srilagna Sarkar, Amity University Kolkata Tata Medical and Diagnostics are in talks to team up with India’s Council of Scientific and Industrial Research in order to carry out Moderna’s vaccine candidate in India. Tata Group’s healthcare venture is said to have started the initial discussion with Moderna Inc on partnership in launching its COVID-19 vaccine […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy